KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.30 $2.95 Thursday, 25th Apr 2024 CLLS stock ended at $2.49. This is 0.400% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 5.85% from a day low at $2.47 to a day high of $2.61.
90 days $2.30 $3.13
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Oct 30, 2020 $16.37 $16.46 $15.62 $15.91 159 299
Oct 29, 2020 $16.52 $16.76 $16.26 $16.36 165 857
Oct 28, 2020 $16.72 $16.96 $16.45 $16.67 176 750
Oct 27, 2020 $17.48 $17.97 $17.26 $17.44 96 344
Oct 26, 2020 $18.79 $19.01 $17.29 $17.78 155 718
Oct 23, 2020 $17.68 $19.79 $17.58 $19.41 326 827
Oct 22, 2020 $17.00 $18.19 $17.00 $17.85 172 595
Oct 21, 2020 $18.16 $18.16 $17.07 $17.08 195 653
Oct 20, 2020 $18.18 $18.60 $17.76 $18.08 298 354
Oct 19, 2020 $19.45 $19.89 $18.18 $18.56 145 359
Oct 16, 2020 $18.76 $19.98 $18.06 $19.68 306 214
Oct 15, 2020 $20.28 $20.38 $19.01 $19.32 285 068
Oct 14, 2020 $21.91 $22.58 $21.50 $21.92 241 694
Oct 13, 2020 $19.58 $21.42 $19.36 $20.88 185 811
Oct 12, 2020 $20.15 $20.43 $19.81 $20.24 142 111
Oct 09, 2020 $19.41 $20.38 $19.41 $20.06 180 448
Oct 08, 2020 $18.77 $19.48 $18.77 $19.38 221 582
Oct 07, 2020 $18.11 $18.63 $18.04 $18.43 140 558
Oct 06, 2020 $18.24 $18.79 $18.05 $18.11 146 904
Oct 05, 2020 $17.19 $18.14 $16.95 $18.06 167 040
Oct 02, 2020 $18.29 $18.42 $17.00 $17.27 211 405
Oct 01, 2020 $18.85 $18.93 $18.27 $18.43 126 353
Sep 30, 2020 $18.39 $19.07 $18.23 $18.50 141 807
Sep 29, 2020 $18.50 $18.66 $18.05 $18.56 126 785
Sep 28, 2020 $18.56 $18.80 $17.88 $18.50 126 116
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT